Inventor · disambiguated record
Markus Johnsson
Also filed as: JOHNSSON MARKUS
35 granted patents·30 pending applications·327 citations·filing 2004–2025
97Inventor score
Top patents by PatentIndex Score
65 records- 0196US11135215B2Opioid formulationsCAMURUS AB·Filed 2021·Granted Oct 5, 2021·3 cites·30 claims
- 0296US10912772B2Opioid formulationsCAMURUS AB·Filed 2020·Granted Feb 9, 2021·4 cites·16 claims
- 0396US8236755B2Opioid depot formulationsTHURESSON KRISTER·Filed 2007·Granted Aug 7, 2012·51 cites·25 claims
- 0495US11135264B2Formulations containing a somatostatin receptor agonistCAMURUS AB·Filed 2020·Granted Oct 5, 2021·3 cites·32 claims
- 0595US8541400B2Compositions forming non-lamellar dispersionsJOHNSSON MARKUS·Filed 2005·Granted Sep 24, 2013·60 cites·22 claims
- 0695US8236292B2Liquid depot formulationsTHURESSON KRISTER·Filed 2005·Granted Aug 7, 2012·41 cites·24 claims
- 0795US8097239B2Controlled-release formulationsJOHNSSON MARKUS·Filed 2007·Granted Jan 17, 2012·42 cites·6 claims
- 0894US12161640B2Opioid formulationsCAMURUS AB·Filed 2023·Granted Dec 10, 2024·1 cites·10 claims
- 0994US11110084B2Opioid formulationsCAMURUS AB·Filed 2021·Granted Sep 7, 2021·2 cites·30 claims
- 1094US10688148B2Formulations containing a somatostatin receptor agonistCAMURUS AB·Filed 2019·Granted Jun 23, 2020·7 cites·49 claims
- 1193US8546326B2Glp-1 analogue formulationsJOABSSON FREDRIK·Filed 2006·Granted Oct 1, 2013·28 cites·15 claims
- 1292US8545832B2Lipid depot formulationsTHURESSON KRISTER·Filed 2012·Granted Oct 1, 2013·15 cites·33 claims
- 1391US9585959B2Robust controlled-release formulationsCAMURUS AB·Filed 2012·Granted Mar 7, 2017·16 cites·34 claims
- 1491US2025281407A1Lipid depot formulationsCAMURUS AB·Filed 2024·Application pending·0 cites
- 1590US11564968B2Formulations containing a somatostatin receptor agonistCAMURUS AB·Filed 2021·Granted Jan 31, 2023·1 cites·31 claims
- 1690US9526788B2Pharmaceutical lipid compositionsCAMURUS AB·Filed 2015·Granted Dec 27, 2016·8 cites·25 claims
- 1788US12029813B2Injectable buprenorphine formulationCAMURUS AB·Filed 2021·Granted Jul 9, 2024·1 cites·22 claims
- 1887US12396944B2Injectable buprenorphine formulationCAMURUS AB·Filed 2024·Granted Aug 26, 2025·0 cites·20 claims
- 1987US12318379B2Opioid formulationsCAMURUS AB·Filed 2024·Granted Jun 3, 2025·0 cites·10 claims
- 2087US9937164B2Opioid formulationsCAMURUS AB·Filed 2013·Granted Apr 10, 2018·7 cites·28 claims
- 2187US8182834B2Ternary non-lamellar lipid compositionsJOHNSSON MARKUS·Filed 2005·Granted May 22, 2012·16 cites·12 claims
- 2286US2025000982A1Peptide slow-release formulationsCAMURUS AB·Filed 2024·Application pending·0 cites
- 2385US11241476B2Mixtures and formulations comprising an alkyl ammonium EDTA saltCAMURUS AB·Filed 2017·Granted Feb 8, 2022·1 cites·24 claims
- 2484US9668967B2Lipid formulations comprising a thiolated antioxidantNISTOR CATALIN·Filed 2009·Granted Jun 6, 2017·3 cites·13 claims
- 2583US9974861B2Peptide slow-release formulationsJOHNSSON MARKUS·Filed 2008·Granted May 22, 2018·4 cites·21 claims
- 2683US9555118B2Robust controlled-release peptide formulationsCAMURUS AB·Filed 2012·Granted Jan 31, 2017·5 cites·36 claims
- 2782US9820934B2Acid containing lipid formulationsNISTOR CATALIN·Filed 2008·Granted Nov 21, 2017·2 cites·25 claims
- 2882US2023027339A1Lipid depot formulationsCAMURUS AB·Filed 2022·Application pending·0 cites
- 2981US2025319097A1Prostacyclin analogue formulationsCAMURUS AB·Filed 2024·Application pending·0 cites
- 3081US2025121035A1Controlled release peptide formulationsCAMURUS AB·Filed 2024·Application pending·0 cites
- 3180US12257282B2Mixtures and formulationsCAMURUS AB·Filed 2022·Granted Mar 25, 2025·0 cites·38 claims
- 3279US11672843B2Somatostatin receptor agonist formulationsCAMURUS AB·Filed 2013·Granted Jun 13, 2023·1 cites·29 claims
- 3378US8871712B2Somatostatin analogue formulationsJOABSSON FREDRIK·Filed 2005·Granted Oct 28, 2014·2 cites·33 claims
- 3477US2023372436A1Somatostatin receptor agonist formulationsCAMURUS AB·Filed 2023·Application pending·0 cites
- 3576US2025345385A1Mixtures and formulations comprising an alkyl ammonium edta saltCAMURUS AB·Filed 2025·Application pending·0 cites
- 3674US2025186536A1Sustained release peptide formulationsRHYTHM PHARMACEUTICALS INC·Filed 2024·Application pending·0 cites
- 3774US2021128473A1Lipid depot formulationsCAMURUS AB·Filed 2020·Application pending·0 cites
- 3873US2021268112A1Peptide slow-release formulationsCAMURUS AB·Filed 2021·Application pending·0 cites
- 3973US2022387445A1Prostacyclin analogue formulationsCAMURUS AB·Filed 2022·Application pending·0 cites
- 4069US2021308226A1Controlled release peptide formulationsCAMURUS AB·Filed 2021·Application pending·0 cites
- 4168US2018311163A1Lipid depot formulationsCAMURUS AB·Filed 2018·Application pending·0 cites
- 4267US2015064118A1Lipid depot formulationsCAMURUS AB·Filed 2014·Application pending·0 cites
- 4366US11369617B2Prostacyclin analogue formulationsCAMURUS AB·Filed 2017·Granted Jun 28, 2022·0 cites·31 claims
- 4466US2019350841A1Lipid formulations comprising a thiolated antioxidantCAMURUS AB·Filed 2018·Application pending·0 cites
- 4565US11433120B2Controlled release peptide formulationsTIBERG FREDRIK·Filed 2012·Granted Sep 6, 2022·1 cites·28 claims
- 4664US2014193347A1Lipid depot formulationsCAMURUS AB·Filed 2013·Application pending·0 cites
- 4763US2023285502A1Mixtures and formulationsCAMURUS AB·Filed 2023·Application pending·0 cites
- 4862US2019054177A1Peptide slow-release formulationsCAMURUS AB·Filed 2018·Application pending·0 cites
- 4961US2018250286A1Opioid formulationsCAMURUS AB·Filed 2018·Application pending·0 cites
- 5061US2017281537A1Lipid formulations comprising a thiolated antioxidantCAMURUS AB·Filed 2017·Application pending·0 cites
Showing the top 50 of 65 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Markus Johnsson files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →